Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France · Delayed Price · Currency is EUR 0.3700
-0.0370 (-9.09%)
Last updated: Jun 3, 2026, 2:27 PM CET
EPA:ALOPM Market Cap
EPA:ALOPM has a market cap or net worth of €7.75 million as of June 3, 2026. Its market cap has increased by 18.48% in one year.
Market Cap
7.75M
Enterprise Value
12.02M
Revenue
1.81M
Ranking
n/a
PE Ratio
1.36
Stock Price
€0.37
Market Cap Chart
Since October 5, 2022, EPA:ALOPM's market cap has increased from 5.82M to 7.75M, an increase of 33.07%. That is a compound annual growth rate of 8.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 7.75M | 3.79% |
| Dec 31, 2025 | 7.47M | -42.44% |
| Dec 31, 2024 | 12.97M | -56.74% |
| Dec 29, 2023 | 29.99M | 155.14% |
| Dec 30, 2022 | 11.75M | 101.80% |
| Oct 5, 2022 | 5.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| genOway Société anonyme | 22.04M |
| GenSight Biologics | 20.75M |
| Aelis Farma | 17.13M |
| NFL Biosciences | 13.00M |
| Advicenne | 12.73M |
| Aton | 12.59M |
| Poxel | 12.30M |
| TME Pharma | 8.10M |